{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T01:26:50Z","timestamp":1770686810155,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1124\/dmd.121.000513","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T22:40:12Z","timestamp":1623883212000},"page":"718-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Differences in Hydrolase Activities in the Liver and Small Intestine between Marmosets and Humans"],"prefix":"10.1016","volume":"49","author":[{"given":"Shiori","family":"Honda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiya","family":"Hirosawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Tsujiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.121.000513_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1026488408951","article-title":"Insect cells as hosts for the expression of recombinant glycoproteins","volume":"16","author":"Altmann","year":"1999","journal-title":"Glycoconj J"},{"key":"10.1124\/dmd.121.000513_bib2","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/dmd.116.070763","article-title":"Prevalence of non-cytochrome P450-mediated metabolism in Food and Drug Administration-approved oral and intravenous drugs: 2006-2015","volume":"44","author":"Cerny","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000513_bib3","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1124\/dmd.110.034249","article-title":"Involvement of carboxylesterase 1 and 2 in the hydrolysis of mycophenolate mofetil","volume":"38","author":"Fujiyama","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000513_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejps.2015.07.006","article-title":"Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases","volume":"78","author":"Fukami","year":"2015","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.121.000513_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bcp.2016.07.007","article-title":"Human arylacetamide deacetylase hydrolyzes ketoconazole to trigger hepatocellular toxicity","volume":"116","author":"Fukami","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.121.000513_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2133\/dmpk.DMPK-12-RV-042","article-title":"The emerging role of human esterases","volume":"27","author":"Fukami","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.121.000513_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/PL00005049","article-title":"The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes. Differential hydrolysis for the lactone and carboxylate forms","volume":"356","author":"Haaz","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/dmd.121.000513_bib8","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1124\/dmd.113.051714","article-title":"Prilocaine- and lidocaine-induced methemoglobinemia is caused by human carboxylesterase-, CYP2E1-, and CYP3A4-mediated metabolic activation","volume":"41","author":"Higuchi","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000513_bib9","doi-asserted-by":"crossref","first-page":"105807","DOI":"10.1016\/j.ejps.2021.105807","article-title":"Hydrolase activities of cynomolgus monkey liver microsomes and recombinant CES1, CES2, and AADAC","volume":"161","author":"Honda","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.121.000513_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules13020412","article-title":"Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs","volume":"13","author":"Hosokawa","year":"2008","journal-title":"Molecules"},{"key":"10.1124\/dmd.121.000513_bib11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1124\/dmd.105.004226","article-title":"Identification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption","volume":"33","author":"Imai","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000513_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2133\/dmpk.21.173","article-title":"Human carboxylesterase isozymes: catalytic properties and rational drug design","volume":"21","author":"Imai","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.121.000513_bib13","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1124\/dmd.106.009381","article-title":"Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine","volume":"34","author":"Imai","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000513_bib14","doi-asserted-by":"crossref","first-page":"105143","DOI":"10.1016\/j.ejps.2019.105143","article-title":"Strain and sex differences in drug hydrolase activities in rodent livers","volume":"142","author":"Kisui","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.121.000513_bib15","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1124\/dmd.115.064089","article-title":"Characterization of species differences in tissue diltiazem deacetylation identifies Ces2a as a rat-specific diltiazem deacetylase","volume":"43","author":"Kurokawa","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000513_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/dmd.115.068221","article-title":"Arylacetamide deacetylase is responsible for activation of prasugrel in human and dog","volume":"44","author":"Kurokawa","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000513_bib17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bcp.2013.10.001","article-title":"N-Glycosylation during translation is essential for human arylacetamide deacetylase enzyme activity","volume":"87","author":"Muta","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.121.000513_bib18","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.bcp.2011.08.003","article-title":"Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine","volume":"82","author":"Nakajima","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.121.000513_bib19","doi-asserted-by":"crossref","first-page":"20498","DOI":"10.1016\/S0021-9258(18)54952-8","article-title":"The COOH terminus of several liver carboxylesterases targets these enzymes to the lumen of the endoplasmic reticulum","volume":"266","author":"Robbi","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.121.000513_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature08090","article-title":"Generation of transgenic non-human primates with germline transmission","volume":"459","author":"Sasaki","year":"2009","journal-title":"Nature"},{"key":"10.1124\/dmd.121.000513_bib21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/dmd.111.043208","article-title":"Conclusive identification of the oxybutynin-hydrolyzing enzyme in human liver","volume":"40","author":"Sato","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000513_bib22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1124\/dmd.112.045054","article-title":"Simultaneous absolute protein quantification of carboxylesterases 1 and 2 in human liver tissue fractions using liquid chromatography-tandem mass spectrometry","volume":"40","author":"Sato","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000513_bib23","doi-asserted-by":"crossref","unstructured":"Shimizu M, Fukami T, Ito Y, Kurokawa T, Kariya M, Nakajima M, and Yokoi T (2014) Indiplon is hydrolyzed by arylacetamide deacetylase in human liver. Drug Metab Dispos 42:751\u2013758.","DOI":"10.1124\/dmd.113.056184"},{"key":"10.1124\/dmd.121.000513_bib24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1124\/dmd.104.000554","article-title":"Identification of the cytosolic carboxylesterase catalyzing the 5\u2032-deoxy-5-fluorocytidine formation from capecitabine in human liver","volume":"32","author":"Tabata","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000513_bib25","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.lfs.2007.07.026","article-title":"Carboxylesterase in the liver and small intestine of experimental animals and human","volume":"81","author":"Taketani","year":"2007","journal-title":"Life Sci"},{"key":"10.1124\/dmd.121.000513_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1389200219666181003143312","article-title":"Survey of drug oxidation activities in hepatic and intestinal microsomes of individual common marmosets, a new nonhuman primate animal model","volume":"20","author":"Uehara","year":"2019","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.121.000513_bib27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1124\/dmd.111.039628","article-title":"Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2","volume":"39","author":"Wang","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000513_bib28","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1124\/dmd.109.026567","article-title":"Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis","volume":"37","author":"Watanabe","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000513_bib29","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1124\/dmd.110.033720","article-title":"Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophen","volume":"38","author":"Watanabe","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000513_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejps.2017.09.040","article-title":"Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans","volume":"111","author":"Yoshida","year":"2018","journal-title":"Eur J Pharm Sci"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624076979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624076979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.121.000513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:18:06Z","timestamp":1739956686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624076979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0090955624076979"],"URL":"https:\/\/doi.org\/10.1124\/dmd.121.000513","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in Hydrolase Activities in the Liver and Small Intestine between Marmosets and Humans","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.121.000513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}